The Latest in Hematology Times

Potential therapeutic target for type of AML

April 25, 2018

FDA places tazemetostat trials on partial hold

April 25, 2018

Improving education for pediatric cancer caregivers

April 25, 2018

Drug receives orphan designation for ALL

April 25, 2018

GO approved to treat AML in Europe

April 24, 2018

Exercise linked to risk of death in cancer patients

April 24, 2018

Company stops development of drug for AL amyloidosis

April 24, 2018

Multiple Myeloma

Art education benefits blood cancer patients

April 23, 2018

Therapy shows early promise in phase 1 MM trial

April 22, 2018

Multiple Myeloma

BET inhibitor has lasting effects in AML, MM

April 21, 2018

Study reveals gene variants that predispose kids to ALL

April 20, 2018

Inhibitor outperforms rivals in leukemia, lymphoma

April 20, 2018

Team uses iPSCs to create ‘universal’ CAR T cells

April 20, 2018

Groups launch open portal for cancer models

April 20, 2018

Gene therapy exceeds expectations in β-thalassemia

April 19, 2018

Anemia